ES2628944T3 - Método para la evaluación de la función de fagocitos - Google Patents

Método para la evaluación de la función de fagocitos Download PDF

Info

Publication number
ES2628944T3
ES2628944T3 ES09750665.3T ES09750665T ES2628944T3 ES 2628944 T3 ES2628944 T3 ES 2628944T3 ES 09750665 T ES09750665 T ES 09750665T ES 2628944 T3 ES2628944 T3 ES 2628944T3
Authority
ES
Spain
Prior art keywords
phagocyte
evaluation
phagocyte function
function
enveloped
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09750665.3T
Other languages
English (en)
Inventor
Katsuki Naito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2628944T3 publication Critical patent/ES2628944T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Método para evaluar la función de un fagocito que comprende las etapas de (i) poner un fagocito en contacto con una sustancia que va a envolverse por el fagocito, (ii) medir sCD14-ST producida por el fagocito, y (iii) comparar el valor medido con un valor de patrón para determinar la presencia y/o el grado de la actividad fagocítica del fagocito.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14

Claims (1)

  1. imagen1
    imagen2
ES09750665.3T 2008-05-23 2009-05-22 Método para la evaluación de la función de fagocitos Active ES2628944T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008135966 2008-05-23
JP2008135966 2008-05-23
PCT/JP2009/059453 WO2009142303A1 (ja) 2008-05-23 2009-05-22 食細胞の機能評価方法

Publications (1)

Publication Number Publication Date
ES2628944T3 true ES2628944T3 (es) 2017-08-04

Family

ID=41340229

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09750665.3T Active ES2628944T3 (es) 2008-05-23 2009-05-22 Método para la evaluación de la función de fagocitos

Country Status (7)

Country Link
US (2) US9476872B2 (es)
EP (1) EP2280279B1 (es)
JP (2) JP5435587B2 (es)
CN (1) CN102037359B (es)
CA (1) CA2725144C (es)
ES (1) ES2628944T3 (es)
WO (1) WO2009142303A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120309025A1 (en) * 2010-01-29 2012-12-06 Mochida Pharmaceutical Co., Ltd METHOD OF ANALYZING HUMAN sCD14-ST
US20130280252A1 (en) * 2011-01-06 2013-10-24 Mochida Pharmaceutical Co., Ltd. Method for selecting patient to be given drug for treating septicemia
KR20140044773A (ko) * 2011-01-11 2014-04-15 미쓰비시 가가쿠 메디엔스 가부시키가이샤 패혈증 예후의 예측 방법
RU2445626C1 (ru) * 2011-02-28 2012-03-20 Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" Способ определения функциональной способности фагоцитирующих клеток
EP2711710B1 (en) * 2011-05-19 2017-04-26 Mochida Pharmaceutical Co., Ltd. Diagnosis of respiratory tract infectious diseases using urine specimens
CA2836562C (en) * 2011-05-19 2021-04-27 Kamon Shirakawa Diagnosis of respiratory tract infectious disease using blood specimens
ES2578160T3 (es) * 2011-08-12 2016-07-21 Lsi Medience Corporation Procedimiento de diagnóstico de infecciones de sitio quirúrgico
KR102360851B1 (ko) 2014-02-26 2022-02-09 모찌다 세이야쿠 가부시끼가이샤 신규 항프레세프신 항체
WO2017033281A1 (ja) 2015-08-25 2017-03-02 持田製薬株式会社 特異的に精製された抗プレセプシン抗体
JP6600527B2 (ja) * 2015-10-15 2019-10-30 自然免疫制御技術研究組合 貪食能評価方法及び蛍光測定方法
US11026277B2 (en) * 2019-01-22 2021-06-01 Galaxy Next Generation, Inc. Assistive listening system that uses sound waves for device pairing
WO2023277130A1 (ja) * 2021-06-30 2023-01-05 株式会社Ｌｓｉメディエンス 尿細管間質障害の検出用バイオマーカー並びにその用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074789A2 (en) * 2001-03-20 2002-09-26 Baylor College Of Medicine Use of monoclonal antibodies and functional assays for prediction of risk of opportunistic infection
US7608684B2 (en) 2002-11-12 2009-10-27 Mochida Pharmaceuticals Co., Ltd. Soluble CD14 antigen
EP1746104B1 (en) 2004-05-11 2013-03-20 Mochida Pharmaceutical Co., Ltd. Novel soluble cd14 antigen
FR2900936B1 (fr) 2006-05-15 2013-01-04 Exonhit Therapeutics Sa Procede et methodes de detection de la maladie d'alzheimer

Also Published As

Publication number Publication date
EP2280279A4 (en) 2011-06-29
CN102037359B (zh) 2017-12-12
JP5435587B2 (ja) 2014-03-05
US10852302B2 (en) 2020-12-01
CA2725144C (en) 2018-11-06
JPWO2009142303A1 (ja) 2011-09-29
JP5788956B2 (ja) 2015-10-07
CN102037359A (zh) 2011-04-27
WO2009142303A1 (ja) 2009-11-26
EP2280279A1 (en) 2011-02-02
US20110086381A1 (en) 2011-04-14
EP2280279B1 (en) 2017-05-03
US9476872B2 (en) 2016-10-25
JP2014052387A (ja) 2014-03-20
CA2725144A1 (en) 2009-11-26
US20160377615A1 (en) 2016-12-29

Similar Documents

Publication Publication Date Title
ES2628944T3 (es) Método para la evaluación de la función de fagocitos
MX2014014244A (es) Determinacion de las concentraciones de tensioactivo residual en el agua producida.
AR071076A1 (es) Aparato, disposicion y metodo para medir caracteristicas de una rosca en un extremo de cano o tuberia
HN2010001437A (es) Metodo y aparato para supervisar una cinta transportadora
BR112012027816A2 (pt) marcadores preditivos úteis no tratamento da síndrome do x frágil (fxs).
ES2527776T3 (es) Biomarcadores para predecir la sensibilidad de células a compuestos inmunomoduladores durante el tratamiento del linfoma no Hodgkin
CL2012000415A1 (es) Sistema elevador de puerta elevadiza que comprende un elevador, un sistema de medicion para medir al menos un parametro de operacion del elevador, un sistema de registro para registrar las mediciones relacionadas con al menos una operacion de elevador y un sistema de respuesta.
CO6680668A2 (es) Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor
MX2015012304A (es) Metodo no invasivo para la medicion de metabolitos para la salud de la piel.
CR20130657A (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
GB2495998B (en) Measurement apparatus
AR085627A1 (es) Procedimiento y dispositivo para el control del funcionamiento correcto de un ascensor
ES2531137T3 (es) Clasificación de señales de audio basada en marcos
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
BR112013006319A2 (pt) configuração de sensor de pressão para o tanque pressurizado
AR098888A1 (es) Composición para el cuidado oral
ES2571135T3 (es) Método de calibración de sensor de glucosa
AR064597A1 (es) Sistema y metodo para medir un parametro de calidad de una cosecha en una cosechadora
ES2544984T3 (es) Detección de la descomposición de enzimas en un elemento de ensayo por liberación controlada de un analito protegido
UY29918A1 (es) Reactivo para sensores de prueba que contiene polimeros de celulosa
DE602006013034D1 (de) Ntrationen in körperflüssigkeiten
BR112013013288A2 (pt) método, reagente e kit para medir um componente a ser medido em uma amostra, e, método para suprimir a influência de um peróxido sobre o dito método
BR112014014279A8 (pt) método para obter dados úteis para o diagnóstico e/ou prognóstico de insuficiência renal aguda; uso de pelo menos um micro-rna; kit para o diagnóstico e/ou prognóstico de insuficiência renal aguda e uso do kit
ES2578160T3 (es) Procedimiento de diagnóstico de infecciones de sitio quirúrgico
ES2548902T3 (es) Procedimiento para la identificación de moduladores de catecol O-metiltransferasa